QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-neutral-on-calix-raises-price-target-to-75

JP Morgan analyst Samik Chatterjee maintains Calix (NYSE:CALX) with a Neutral and raises the price target from $60 to $75.

 rosenblatt-maintains-buy-on-calix-raises-price-target-to-85

Rosenblatt analyst Mike Genovese maintains Calix (NYSE:CALX) with a Buy and raises the price target from $65 to $85.

 needham-maintains-buy-on-calix-raises-price-target-to-82

Needham analyst Ryan Koontz maintains Calix (NYSE:CALX) with a Buy and raises the price target from $70 to $82.

 roth-capital-maintains-buy-on-calix-raises-price-target-to-69

Roth Capital analyst Scott Searle maintains Calix (NYSE:CALX) with a Buy and raises the price target from $60 to $69.

 rosenblatt-maintains-buy-on-calix-maintains-65-price-target

Rosenblatt analyst Mike Genovese maintains Calix (NYSE:CALX) with a Buy and maintains $65 price target.

 needham-maintains-buy-on-calix-raises-price-target-to-70

Needham analyst Ryan Koontz maintains Calix (NYSE:CALX) with a Buy and raises the price target from $60 to $70.

 rosenblatt-maintains-buy-on-calix-raises-price-target-to-65

Rosenblatt analyst Mike Genovese maintains Calix (NYSE:CALX) with a Buy and raises the price target from $56 to $65.

 calix-sees-q3-adj-eps-031-037-vs-023-est-sees-sales-243000m-249000m-vs-22702m-est

Calix (NYSE:CALX) is looking for Q3 Adj EPS of $0.31-$0.37 vs $0.23 analyst estimate. sees sales of $243.000 million-$249.000 m...

 calix-q2-adj-eps-033-beats-021-estimate-sales-24190m-beat-22379m-estimate

Calix (NYSE:CALX) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.21 by 57.14 pe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION